Engineering Cortical Networks: An Open Platform for Controlled Human Circuit Formation and Synaptic Analysis In Vitro
Advanced Healthcare Materials · 2025-12 · 14 (31)
DOI: 10.1002/adhm.202500857 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 24.10.2025. Verfasst von Pacharaporn Suklai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Clinical Neuroscience, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, SE5 9RX, UK. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Synapses, Nerve Net, Neurons. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neuronal circuits are organized by specific connections between neuron types across various brain regions. Understanding how these circuits form is crucial for uncovering the mechanisms behind circuit‐related dysfunction in brain diseases. Human‐induced pluripotent stem cell (iPSC) models enable the study of the molecular and cellular processes underlying neuronal networks, but their lack of precise architecture limits the investigation of specific neuronal interactions and activity‐dependent processes. Microfluidic technologies offer structural control but are confined by closed systems that restrict 3D network integration, scalability, and cell retrieval. To overcome these challenges, we developed an open cortical network platform that integrates iPSC‐derived cortical neurons with bioengineering techniques. Using a polydimethylsiloxane‐based microgroove topography and a cell plating guide, we created “neuronal nodes” that facilitate flexible circuit construction in an open system. This design allows optogenetic control of neural activity and flexible network modifications, including cellular composition, neurite directionality, and synapse formation. The open, large‐scale design allows neuronal material retrieval, supporting multi‐level analyses of cortical circuits, such as proteomics. This platform represents a valuable tool for investigating neuronal network development and function, providing opportunities for study into both normal and pathological states, including molecular changes associated with connectivity loss in brain diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic and Clinical Neuroscience, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, SE5 9RX, UK.
- UK Dementia Research Institute at King's College London, London, SE5 9RX, UK.
- The Francis Crick Institute, London, NW1 1AT, UK.
- Medical Research Council (MRC) Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK.
- Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
ORCID-Profile: Andrea Serio
Zitieren
APA
Suklai, P., Minckley, T., Hagemann, C., Faber, K., Norkett, R., Guetta, L., O'Toole, K., Geary, B., Devine, M. J., & Serio, A. (2025). Engineering Cortical Networks: An Open Platform for Controlled Human Circuit Formation and Synaptic Analysis In Vitro. Advanced Healthcare Materials, 14(31). https://doi.org/10.1002/adhm.202500857
Vancouver
Suklai P, Minckley T, Hagemann C, Faber K, Norkett R, Guetta L, et al. Engineering Cortical Networks: An Open Platform for Controlled Human Circuit Formation and Synaptic Analysis In Vitro. Advanced Healthcare Materials. 2025;14(31). doi:10.1002/adhm.202500857
BibTeX
@article{Suklai2025,
author = {Suklai, Pacharaporn and Minckley, Taylor and Hagemann, Cathleen and Faber, Karolina and Norkett, Rosalind and Guetta, Ludovica and O'Toole, Kelly and Geary, Bethany and Devine, Michael J and Serio, Andrea},
title = {Engineering Cortical Networks: An Open Platform for Controlled Human Circuit Formation and Synaptic Analysis In Vitro},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {31},
doi = {10.1002/adhm.202500857}
}
EUVIMED